Technical analysis of Aptevo Therapeutics Inc. (APVO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes.
Price Performance
| 1 month | -40.69% |
| 3 months | -63.17% |
| Year-to-date | -81.76% |
| 1 year | -93.22% |
| 3 years | -100.00% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $48.78 |
| 52-week Low | $1.37 |
| Avg Volume (90d) | 83K |
Technical Indicators
| SMA 50 | $3.32 |
| SMA 200 | $6.72 |
| Beta | 1.51 |
| 30-day Volatility (annualised) | 144.5% |
| Price vs SMA 50 | -48.1% |
| Price vs SMA 200 | -74.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $27.90 | |
| 2025-11 | $24.84 | -11.0% |
| 2025-12 | $9.43 | -62.0% |
| 2026-01 | $7.27 | -22.9% |
| 2026-02 | $7.32 | +0.7% |
| 2026-03 | $4.27 | -41.7% |
| 2026-04 | $4.85 | +13.6% |
| 2026-05 | $4.91 | +1.2% |
| 2026-06 | $4.44 | -9.6% |
| 2026-07 | $4.11 | -7.4% |
| 2026-08 | $2.44 | -40.6% |
| 2026-09 | $1.72 | -29.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.72 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.24 |
| EV / EBITDA | 0.07 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.70 |
| Current Ratio | 2.08 |